Cure SZT2 is a non-profit organization dedicated solely to patients and families affected by the ultra-rare genetic mutation SZT2. Our mission is to improve the lives of children and families affected by SZT2. The “cure SZT2” group focuses mainly on raising and directing funds to scientific research with the goal of finding better, more effective treatments and, ultimately, a cure.
FROM LAB TO CLINIC: GENETIC RESEARCH IS CHANGING EPILEPSY TREATMENT
Dr. Gemma Carvill, a former CURE Grantee who is a leader in epilepsy genetic research, was awarded a Taking Flight Award in 2015, early in her career. This grant aims to encourage young investigators to conduct independent research and blossom in the field of epilepsy. Her intriguing study explored how genetic mutations can cause epilepsy to develop, particularly a group of severe, treatment-resistant childhood epilepsy syndromes called “epileptic encephalopathy”.
Since receiving her CURE grant, Dr. Carvill’s career has certainly “taken flight”. Today, she heads her own lab at Northwestern University in Chicago, IL, where her team continues to focus on understanding the underlying genetic and epigenetic mechanisms of epilepsy.
We had the chance to catch up with Dr. Carvill during a recently aired episode of our Seizing Life®podcast. Watch or Listen to learn more about epilepsy genetics and Dr. Carvill's exciting research.